-
1 Comment
Carl Zeiss Meditec AG is currently in a long term uptrend where the price is trading 28.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.8.
Carl Zeiss Meditec AG's total revenue sank by 0.2% to $369M since the same quarter in the previous year.
Its net income has increased by 19.3% to $46M since the same quarter in the previous year.
Finally, its free cash flow grew by 53.4% to $40M since the same quarter in the previous year.
Based on the above factors, Carl Zeiss Meditec AG gets an overall score of 4/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | DE0005313704 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Beta | 1.23 |
|---|---|
| Market Cap | 5B |
| PE Ratio | 32.97 |
| Target Price | 61.2188 |
| Dividend Yield | 1.0% |
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics, as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AFX.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
